As more drug that prevents H.I.V. infection are roll out, the more the reduction in condom

According to a research, as more drug that prevents H.I.V. infection are roll out, the more the reduction in condom use among gay and bisexual men in Australia, according to a study published in the journal Lancet H.I.V.
The drug was so effective that H.I.V. infection rates in the study region declined.
During the rapid distribution of a drug that prevents infection — a strategy called pre-exposure prophylaxis, or PrEP — among gay and bisexual men in Australia, researchers found that unprotected sex increased even among those not on PrEP, suggesting that perceptions of risk had declined in communities where the drug was widely available.
“Safe sex is basically transformed by PrEP,” said Martin Holt, a researcher at University of New South Wales in Sydney, who led the study.
“It’s great that these guys are feeling optimistic about avoiding H.I.V., but it has disrupted prevention methods at a community level.”
The daily pill is highly effective in combating H.I.V. infection and is recommended for at-risk populations, such as gay men and intravenous drug users, according to the World Health Organization.





Comments